Cytotoxicity in L929 fibroblasts and inhibition of herpes simplex virus type 1 Kupka by estuarine cyanobacteria extracts

Toxicology in Vitro

Volumn 25, Issue 4, 2011, Pages 944-950

  Lopes, Viviana R ^a,b   Schmidtke, Michaela ^c   Helena Fernandes, M ^d   Martins, Rosário ^a,e,f   Vasconcelos, Vitor ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d U Porto   (Portugal)

^e POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^f UNIVERSITY OF PORTO   (Portugal)

Author keywords

Anti HSV 1 activity; Cytotoxicity; DNA damage; Estuarine cyanobacteria

Indexed keywords

CRYSTAL VIOLET; CYANOBIUM EXTRACT; HEXANE; LEPTOLYNGBYA EXTRACT; METHANOL; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; MICROCOLEUS EXTRACT; NODULARIA EXTRACT; NOSTOC EXTRACT; PHORMIDIUM EXTRACT; SYNECHOCYSTIS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM MUTANT; BIOASSAY; CELL STRAIN L 929; CONCENTRATION RESPONSE; CONTROLLED STUDY; COXSACKIE VIRUS B3; CYANOBACTERIUM; CYANOBIUM; CYTOPATHOGENIC EFFECT; DNA DAMAGE; DNA REPAIR; DRUG CYTOTOXICITY; DRUG EXPOSURE; ESCHERICHIA COLI; ESTUARY; GENOTOXICITY; HELA CELL; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IC 50; INFLUENZA VIRUS A; KIDNEY CELL; LEPTOLYNGBYA; MICROCOLEUS; NODULARIA; NONHUMAN; NOSTOC; PHORMIDIUM; RHINOVIRUS; RHINOVIRUS 2; SOS CHROMOTEST; SYNECHOCYSTIS;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; CYANOBACTERIA; DNA DAMAGE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FIBROBLASTS; HELA CELLS; HERPESVIRUS 1, HUMAN; HUMANS; INHIBITORY CONCENTRATION 50; KIDNEY; MICE; MUTAGENICITY TESTS; SOLVENTS; SOS RESPONSE (GENETICS); VIRUSES;

CYANOBACTERIA; ESCHERICHIA COLI; HERPES; HUMAN HERPESVIRUS 1; HUMAN RHINOVIRUS 2; ORTHOMYXOVIRIDAE;

EID: 79955476228     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.03.003     Document Type: Article

References (42)

1. Abed R.M.M., Dobretsov S., Sudesh K. Applications of cyanobacteria in biotechnology. J. Appl. Microbiol. 2009, 106:1-12.
2. Berridge M.V., Tan A.S. Characterization of the cellular reduction of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 1993, 303:474-482.
3. Bubik A., Sedmak B., Novinec M., Lenarcic B., Lah T.T. Cytotoxic and peptidase inhibitory activities of selected non-hepatotoxic cyclic peptides from cyanobacteria. Biol. Chem. 2008, 389:1339-1346.
4. Burja A.M., Banaigs B., Abou-Mansour E., Grant Burgess J., Wright P.C. Marine cyanobacteria - a prolific source of natural products. Tetrahedron 2001, 57:9347-9377.
5. Carmichael W.W. Toxins of cyanobacteria. Sci. Am. 1994, 270:78-86.
6. Carmichael W.W. Health effects of toxin-producing cyanobacteria: " The CyanoHABs" Hum. Ecol. Risk Assess. 2001, 7:1393-1407.
7. Ding W.-X., Shen H.-M., Zhu H.-G., Lee B.-L., Ong C.-N. Genotoxicity of microcystic cyanobacteria extract of a water source in China. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 1999, 442:69-77.
8. Freshney R.I. Culture of animal cells: a manual of basic technique 2000, Wiley-Liss, New York, USA. fourth ed.
9. Gademann K., Portmann C. Secondary metabolites from cyanobacteria: complex structures and powerful bioactivities. Curr. Org. Chem. 2008, 12:326-341.
10. Hayashi K., Hamada J., Hayashi T. A screening strategy for selection of anti-HSV-1 and anti-HIV extracts from algae. Phytother. Res. 1996, 10:233-237.
11. Hernandez-Corona A., Nieves I., Meckes M., Chamorro G., Barron B.L. Antiviral activity of Spirulina maxima against herpes simplex virus type 2. Antiviral Res. 2002, 56:279-285.
12. Hirata K., Yoshitomi S., Dwi S., Iwabe O., Mahakhant A., Polchai J., Miyamoto K. Bioactivities of nostocine a produced by a freshwater cyanobacterium Nostoc spongiaeforme TISTR 8169. J. Biosci. Bioeng. 2003, 95:512-517.
13. Jaiswal P., Singh P.K., Prasanna R. Cyanobacterial bioactive molecules - an overview of their toxic properties. Can. J. Microbiol. 2008, 54:701-717.
14. Kanekiyo K., Hayashi K., Takenaka H., Lee J.B., Hayashi T. Anti-herpes simplex virus target of an acidic polysaccharide, nostoflan, from the edible blue-green alga Nostoc flagelliforme. Biol. Pharm. Bull. 2007, 30:1573-1575.
15. Kanekiyo K., Lee J.B., Hayashi K., Takenaka H., Hayakawa Y., Endo S., Hayashi T. Isolation of an antiviral polysaccharide, nostoflan, from a terrestrial cyanobacterium, Nostoc flagelliforme. J. Nat. Prod. 2005, 68:1037-1041.
16. Kotai J. Instructions for Preparation of Modified Nutrient Solution Z8 for Algae 1972, Norwegian Institute for Water Research, Blindern, Oslo, Norway.
17. Li J., Song L.R. Applicability of the MTT assay for measuring viability of cyanobacteria and algae, specifically for Microcystis aeruginosa (Chroococcales, Cyanobacteria). Phycologia 2007, 46:593-599.
18. Lopes V., Fernández N., Martins R., Vasconcelos V. Primary screening of the bioactivity of brackishwater cyanobacteria: toxicity of crude extracts to Artemia salina Larvae and Paracentrotus lividus Embryos. Mar. Drugs 2010, 8:471-482.
19. Makarov V.A., Riabova O.B., Granik V.G., Wutzler P., Schmidtke M. Novel [(biphenyloxy)propyl]isoxazole derivatives for inhibition of human rhinovirus 2 and coxsackievirus B3 replication. J. Antimicrob. Chemother. 2005, 55:483-488.
20. Mankiewicz J., Walter Z., Tarczynska M., Palyvoda O., Wojtysiak-Staniaszczyk M., Zalewski M. Genotoxicity of cyanobacterial extracts containing microcystins from Polish water reservoirs as determined by SOS chromotest and comet assay. Environ. Toxicol. 2002, 17:341-350.
21. Martins R., Fernandez N., Beiras R., Vasconcelos V. Toxicity assessment of crude and partially purified extracts of marine Synechocystis and Synechococcus cyanobacterial strains in marine invertebrates. Toxicon 2007, 50:791-799.
22. Martins R., Ramos M., Herfindal L., Sousa J., Skærven K., Vasconcelos V. Antimicrobial and cytotoxic assessment of marine cyanobacteria - Synechocystis and Synechococcus. Mar. Drugs 2008, 6:1-11.
23. Mundt S., Kreitlow S., Nowotny A., Effmert U. Biochemical and pharmacological investigations of selected cyanobacteria. Int. J. Hyg. Environ. Health 2001, 203:327-334.
24. Mundt S., Nowotny A., Mentel R., Lesnau A., Lindequist U. Antiviral activity of the cyanobacterium Microcystis aeruginosa SPH 01. Pharm. Pharmacol. Lett. 1997, 7:161-163.
25. Nowotny A., Mentel R., Wegner U., Mundt S., Lindequist U. Antiviral activity of an aqueous extract of the cyanobacterium Microcystis aeruginosa. Phytother. Res. 1997, 11:93-96.
26. Ohta S., Ono F., Shiomi Y., Nakao T., Aozasa O., Nagate T., Kitamura K., Yamaguchi S., Nishi M., Miyata H. Anti-herpes simplex virus substances produced by the marine green alga, Dunaliella primolecta. J. Appl. Phycol. 1998, 10:349-356.
27. Patterson G.M.L., Baker K.K., Baldwin C.L., Bolis C.M., Caplan F.R., Larsen L.K., Levine I.A., Moore R.E., Moore E., Nelson C.S., Tschappat K.D., Tuang G.D., Boyd M.R., II J.H.C., Collins R.P., Gustafson K.R., Snader K.M., Weislow O.S., Lewin R.A. Antiviral activity of cultured blue-green (Cyanophyta). J. Phycol. 1993, 29:125-130.
28. Patterson G.M.L., Larsen L.K., Moore R.E. Bioactive natural-products from blue-green algae. J. Appl. Phycol. 1994, 6:151-157.
29. Puerto M., Pichardo S., Jos A., Camean A.M. Comparison of the toxicity induced by microcystin-RR and microcystin-YR in differentiated and undifferentiated Caco-2 cells. Toxicon 2009, 54:161-169.
30. Quillardet P., Hofnung M. The SOS chromotest: a review. Mutat. Res. 1993, 297:235-279.
31. Quillardet P., Huisman O., D'Ari R., Hofnung M. SOS Chromotest, a direct assay of induction of an SOS function in Escherichia coli K12 to measure genotoxicity. Proc. Natl. Acad. Sci. 1982, 79:5971-5975.
32. Rechter S., König T., Auerochs S., Thulke S., Walter H., Dörnenburg H., Walter C., Marschall M. Antiviral activity of Arthrospira-derived spirulan-like substances. Antiviral Res. 2006, 72:197-206.
33. Schmidtke M., Schnittler U., Jahn B., Dahse H.M., Stelzner A. A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. J. Virol. Methods 2001, 95:133-143.
34. Shen X., Lam P.K.S., Shaw G.R., Wickramasinghe W. Genotoxicity investigation of a cyanobacterial toxin, cylindrospermopsin. Toxicon 2002, 40:1499-1501.
35. Shirahashi H., Murakami N., Watanabe M., Nagatsu A., Sakakibara J., Tokuda H., Nishino H., Iwashima A. Isolation and identification of anti-tumor-promoting principles from the fresh-water cyanobacterium Phormidium tenue. Chem. Pharm. Bull. (Tokyo) 1993, 41:1664-1666.
36. Surakka A., Sihvonen L.M., Lehtimaki J.M., Wahlsten M., Vuorela P., Sivonen K. Benthic cyanobacteria from the Baltic Sea contain cytotoxic Anabaena, Nodularia, and Nostoc strains and an apoptosis-inducing Phormidium strain. Environ. Toxicol. 2005, 20:285-292.
37. Takamatsu S., Nagle D.G., Gerwick W.H. Secondary metabolites from marine cyanobacteria and algae inhibit LFA-1/ICAM-1 mediated cell adhesion. Planta Med. 2004, 70:127-131.
38. Teneva I., Asparuhova D., Dzhambazov B., Mladenov R., Schirmer K. The freshwater cyanobacterium Lyngbya aerugineo-coerulea produces compounds toxic to mice and to mammalian and fish cells. Environ. Toxicol. 2003, 18:9-20.
39. Teneva I., Dzhambazov B., Koleva L., Mladenov R., Schirmer K. Toxic potential of five freshwater Phormidium species (Cyanoprokaryota). Toxicon 2005, 45:711-725.
40. Wiegand C., Pflugmacher S. Ecotoxicological effects of selected cyanobacterial secondary metabolites a short review. Toxicol. Appl. Pharmacol. 2005, 203:201-218.
41. Zainuddin E.N., Mundt S., Wegner U., Mentel R. Cyanobacteria a potential source of antiviral substances against influenza virus. Med. Microbiol. Immunol. 2002, 191:181-182.
42. Zhan L., Sakamoto H., Sakuraba M., Wu D.-S., Zhang L.-S., Suzuki T., Hayashi M., Honma M. Genotoxicity of microcystin-LR in human lymphoblastoid TK6 cells. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2004, 557:1-6.